Cervical screening: HPV and biomarkers – new options
Cervical cancer is the third most frequent malignancy in women worldwide with almost half a million cases diagnosed each year.1 In Ireland, the annual incidence in 2007 was 286 cases, resulting in 83 deaths.2
Cervical cancer is initiated by progression through a well-defined pre-malignant phase known as...
Read more